Quality of life measures in soft tissue sarcoma

Kenneth Gundle, Amy M. Cizik, Robin L. Jones, Darin J. Davidson

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The assessment of health-related quality of life (HRQL) via patient-reported outcomes has the potential to answer critical questions and improve the care of soft tissue sarcoma (STS). This review outlines the rationale for quality of life measures in sarcoma, and details various instrument types: disease- and anatomic-specific, provider-generated, generic HRQL and health state utilities. Prior usage in STS populations, relative advantages of specific patient-reported outcome measures and a framework for selecting appropriate measures are discussed. Uniform incorporation of validated HRQL measures in STS clinical research would further the understanding of patient wellbeing beyond traditional clinical measures, and more widespread use of health state utilities measures in particular has the potential to facilitate comparative effectiveness research.

Original languageEnglish (US)
Pages (from-to)95-100
Number of pages6
JournalExpert review of anticancer therapy
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Sarcoma
Quality of Life
Comparative Effectiveness Research
Health
Research
Population
Patient Reported Outcome Measures

Keywords

  • clinical research
  • health state utilities
  • health-related quality of life
  • patient-reported outcomes
  • soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Quality of life measures in soft tissue sarcoma. / Gundle, Kenneth; Cizik, Amy M.; Jones, Robin L.; Davidson, Darin J.

In: Expert review of anticancer therapy, Vol. 15, No. 1, 01.01.2014, p. 95-100.

Research output: Contribution to journalReview article

Gundle, Kenneth ; Cizik, Amy M. ; Jones, Robin L. ; Davidson, Darin J. / Quality of life measures in soft tissue sarcoma. In: Expert review of anticancer therapy. 2014 ; Vol. 15, No. 1. pp. 95-100.
@article{2a926a61808f4cbd804b5093dcf3035b,
title = "Quality of life measures in soft tissue sarcoma",
abstract = "The assessment of health-related quality of life (HRQL) via patient-reported outcomes has the potential to answer critical questions and improve the care of soft tissue sarcoma (STS). This review outlines the rationale for quality of life measures in sarcoma, and details various instrument types: disease- and anatomic-specific, provider-generated, generic HRQL and health state utilities. Prior usage in STS populations, relative advantages of specific patient-reported outcome measures and a framework for selecting appropriate measures are discussed. Uniform incorporation of validated HRQL measures in STS clinical research would further the understanding of patient wellbeing beyond traditional clinical measures, and more widespread use of health state utilities measures in particular has the potential to facilitate comparative effectiveness research.",
keywords = "clinical research, health state utilities, health-related quality of life, patient-reported outcomes, soft tissue sarcoma",
author = "Kenneth Gundle and Cizik, {Amy M.} and Jones, {Robin L.} and Davidson, {Darin J.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1586/14737140.2015.972947",
language = "English (US)",
volume = "15",
pages = "95--100",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Quality of life measures in soft tissue sarcoma

AU - Gundle, Kenneth

AU - Cizik, Amy M.

AU - Jones, Robin L.

AU - Davidson, Darin J.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The assessment of health-related quality of life (HRQL) via patient-reported outcomes has the potential to answer critical questions and improve the care of soft tissue sarcoma (STS). This review outlines the rationale for quality of life measures in sarcoma, and details various instrument types: disease- and anatomic-specific, provider-generated, generic HRQL and health state utilities. Prior usage in STS populations, relative advantages of specific patient-reported outcome measures and a framework for selecting appropriate measures are discussed. Uniform incorporation of validated HRQL measures in STS clinical research would further the understanding of patient wellbeing beyond traditional clinical measures, and more widespread use of health state utilities measures in particular has the potential to facilitate comparative effectiveness research.

AB - The assessment of health-related quality of life (HRQL) via patient-reported outcomes has the potential to answer critical questions and improve the care of soft tissue sarcoma (STS). This review outlines the rationale for quality of life measures in sarcoma, and details various instrument types: disease- and anatomic-specific, provider-generated, generic HRQL and health state utilities. Prior usage in STS populations, relative advantages of specific patient-reported outcome measures and a framework for selecting appropriate measures are discussed. Uniform incorporation of validated HRQL measures in STS clinical research would further the understanding of patient wellbeing beyond traditional clinical measures, and more widespread use of health state utilities measures in particular has the potential to facilitate comparative effectiveness research.

KW - clinical research

KW - health state utilities

KW - health-related quality of life

KW - patient-reported outcomes

KW - soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84919789335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919789335&partnerID=8YFLogxK

U2 - 10.1586/14737140.2015.972947

DO - 10.1586/14737140.2015.972947

M3 - Review article

VL - 15

SP - 95

EP - 100

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 1

ER -